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Members of the enterobacterial genus, Serratia, are ecologically widespread and some 23 
strains are opportunistic human pathogens. Bacteriophage φMAM1 was isolated on 24 
Serratia plymuthica A153, a biocontrol rhizosphere strain that produces the potently-25 
bioactive antifungal and anticancer haterumalide, oocydin A. The φMAM1 phage is a 26 
generalized transducing phage that infects multiple environmental and clinical isolates of 27 
Serratia spp. and a rhizosphere strain of Kluyvera cryorescens. Electron microscopy 28 
allowed classification of φMAM1 in the family Myoviridae. Bacteriophage φMAM1 is 29 
virulent, uses capsular polysaccharides as receptor and can transduce chromosomal 30 
markers at frequencies of up to 7 x 10-6 transductants per p.f.u. We also demonstrated 31 
transduction of the complete 77-kb oocydin A gene cluster and heterogeneric transduction 32 
of a Type III Toxin-Antitoxin-encoding plasmid. These results support the notion of the 33 
potential ecological importance of transducing phages in the acquisition of genes by 34 
horizontal gene transfer. Phylogenetic analyses grouped φMAM1 within the ViI-like 35 
bacteriophages and genomic analyses revealed that the major differences between 36 
φMAM1 and other ViI-like phages arise in a region encoding the host-recognition 37 
determinants. Our results predict that the wider genus of ViI-like phages could be efficient 38 
transducing phages - with obvious implications for the ecology of horizontal gene transfer, 39 









Bacteriophages (phages) are ubiquitous obligate viral parasites of bacteria that reproduce, 47 
in concert with their hosts in diverse natural environments (1,2). Bacteriophage abundance 48 
correlates with bacterial population densities in a given niche and the global phage 49 
population has been estimated at over 1031 phages, reflecting over 1025 infections per 50 
second (3,4). This intimate interaction between phages and their hosts results in rapid co-51 
evolution that has been observed under both natural environmental and laboratory 52 
conditions (5-7).  53 
Since discovery in the early 1900s, phages have been used as therapeutic agents in 54 
human infections (8,9), but also as alternative biocontrol agents in agriculture, sewage 55 
treatment and in the food industry (10-13). Furthermore, phage display technology has 56 
proved useful in cancer studies and for the delivery of vaccines (12,13). Additionally, 57 
transducing phages have been important tools in basic bacterial genetics, functional 58 
genomics and synthetic biology applications (13-15).  59 
Together with transformation and conjugation, transduction is one of the three main 60 
classes of horizontal gene transfer (HGT) in bacteria. In generalized transduction, phages 61 
accidentally package large fragments of host bacterial DNA instead of the viral genome. 62 
The generated transducing particles adsorb normally and inject DNA into a recipient 63 
bacterium. The injected bacterial DNA may integrate by homologous recombination into 64 
the genome of the recipient host, resulting in a stable bacterial transductant (14,16). 65 
Transducing phages have been used extensively in genetic manipulations, including 66 
bacterial strain engineering, transposon mutagenesis and plasmid transfer (14,16).  67 
Bacteria of the genus Serratia belong to the family Enterobacteriaceae. Serratia species 68 
are widely distributed, being commonly found in water, soil, plants, animals and man; 69 
some species are opportunistic human pathogens (17). Although Serratia plymuthica 70 
strains have been isolated from diverse environments, they are mostly associated with 71 
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plants and are considered to be plant-growth promoting bacteria and excellent biocontrol 72 
agents for many fungal and oomycete plant diseases (18). Serratia plymuthica A153 was 73 
isolated from the rhizosphere of wheat (19) and produces several halogenated macrolides, 74 
haterumalides (20). Haterumalides – also known as oocydins - were among the first 75 
polyketides found to be synthesised by Serratia species (21) and they have been shown to 76 
exhibit anti-cancer, antifungal, anti-oomycete and anti-hyperlipidemic properties (20-23).  77 
Recently, we isolated and sequenced the new ViI-like Serratia phage, ϕMAM1 (24). Here, 78 
we analyse the genome and report the morphological and biological characterization of 79 
φMAM1, a generalized transducing phage that is able to infect many environmental and 80 
clinical isolates from the Serratia and Kluyvera genera.   81 
      82 
MATERIALS AND METHODS 83 
Bacterial strains, plasmids, phages, culture media and growth conditions. Bacterial 84 
strains and plasmids used in this study are listed in Tables 1 and A1. Serratia, Kluyvera 85 
and their derivative strains were routinely grown at 30 ºC, unless otherwise indicated, in 86 
Luria Broth (LB; 5 g yeast extract l-1,10 g Bacto tryptone l-1 and 5 g NaCl l-1), Potato 87 
Dextrose (24 g potato dextrose broth l-1) or minimal medium (0.1%, w/v, (NH4)2SO4, 0.41 88 
mM MgSO4, 0.2% (w/v) glucose, 40 mM K2HPO4, 14.7 mM KH2PO4, pH 6.9–7.1). 89 
Escherichia coli strains were grown at 37 °C in LB. Escherichia coli DH5α was used for 90 
gene cloning. Media for propagation of E. coli β2163 were supplemented with 300 μM 2,6-91 
diaminopimelic acid (DAPA). When appropriate, antibiotics were used at the following final 92 
concentrations (in µg ml-1): ampicillin, 100; kanamycin, 25 (E. coli strains) and 75 (Serratia 93 
strains); streptomycin, 50; tetracycline, 10. Sucrose was added to a final concentration of 94 
10% (w/v) when required to select derivatives that had undergone a second cross-over 95 
event during marker exchange mutagenesis. Unless indicated, the growth temperature for 96 
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S. plymuthica A153, 30 ºC, was used for the phage incubations. Phages were stored at 4 97 
ºC in phage buffer (10 mM Tris-HCl pH 7.4, 10 mM MgSO4, 0.01% w/v gelatine) over a few 98 
drops of NaHCO3-saturated chloroform. 99 
φMAM1 phage isolation and phage lysate preparation. Treated sewage effluent was 100 
collected from the sewage treatment plant at Milton, Cambridge (United Kingdom) (24). 101 
Briefly, a 10 ml sample of the effluent was filter sterilized. Then 500 µL of the sterilized 102 
effluent was mixed with 200 µL of a Serratia plymuthica A153 overnight culture and 4 mL 103 
of top LB-agar (LBA, 0.35% w/v agar) and poured as an overlay onto LBA plates (1.5% 104 
w/v agar). Plates were incubated overnight at 30 ºC and single phage plaques were picked 105 
with a sterile toothpick into 0.2 ml phage buffer and shaken with 20 µL of chloroform to kill 106 
any bacteria. Phages obtained were plaque-purified three times. High-titre phage lysates 107 
were then obtained as described Petty et al. (25). Phages were titrated by serial dilutions 108 
in phage buffer and the phage titre determined in plaque-forming units (p.f.u.) per millilitre.  109 
φMAM1 genome sequencing. Genomic DNA sequencing was performed using 454 DNA 110 
pyrosequencing technology as described previously (24). The preparation of the 454 111 
library was done by nebulisation using GS FLX Titanium Rapid Library Preparation Kit 112 
following the manufacturer´s instructions (Roche, Cat. No. 05608228001). The shearing 113 
was performed with nitrogen gas at a pressure of 30 psi (2.1 bar) for 1 min. The assembly 114 
used 257,858 reads or 102.6 MB of raw data to give 650X coverage of the genome.  115 
Genome annotation and bioinformatics. Annotation of φMAM1 genome and 116 
identification of tRNAs was performed as described previously (24). Putative bacteriocins 117 
were identified using the web-based bacteriocin mining tool BAGEL2 (University of 118 
Groningen, The Netherlands). Artemis software (Wellcome Trust Sanger Institute) was 119 
used to visualize and annotate the φMAM1 genome. Genome comparison analyses were 120 
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performed employing the Artemis Comparison Tool and EMBOSS Stretcher (European 121 
Bioinformatics Institute). The genomic organization and annotation of the seven previously 122 
reported ViI-like enterobacterial bacteriophages (26) were used to determine the location 123 
of ORF1 in φMAM1. The CGView Comparison Tool (27) was employed to visualize the 124 
φMAM1 genome and to generate Figure 3. Multiple sequence alignments of phage 125 
proteins were performed using ClustalW2 (European Bioinformatics Institute). To analyse 126 
and identify motifs in promoter regions, 100 bp sequences upstream of the start codons 127 
were extracted using extractUpStreamDNA (http://lfz.corefacility.ca/extractUpStreamDNA/) 128 
and analyzed using the MEME Suite (28). Candidate late promoters in φMAM1 were 129 
identified by using the T4 late promoters conserved consensus sequence (TATAAATA). 130 
Rho-independent transcription terminators were identified by examining the secondary 131 
structure of the DNA using ARNold (http://rna.igmors.u-psud.fr/toolbox/arnold/index.php). 132 
The phylogenetic analyses were performed with the MEGA software v5.10 (29). The 133 
φMAM1 GenBank submission file was generated using Sequin (NCBI). The complete 134 
genome sequence of φMAM1 is available in GenBank under Accession Number 135 
JX878496. 136 
Electron microscopy 137 
High-titre lysates for transmission electron microscopy were obtained as described by 138 
Petty et al. (25) using 0.35% (w/v) LB agarose instead of 0.35% (w/v) LB agar overlays. 139 
Twenty-five microlitres of high-titre φMAM1 phage lysates (≥ 3 x 1010 p.f.u. ml-1) were 140 
absorbed onto copper, 400 mesh grids with holey carbon support films (Agar Scientific, 141 
Stansted, UK). Copper grids were discharged in a Quorum/Emitech K100X (Quorum, 142 
Ringmer, UK) prior to use. After 1 min, excess phage suspension was removed with filter 143 
paper and phage samples were negatively stained by placing the grids in 25 µl drops of 144 
2% ammonium tugstate containing 0.1% trehalose (pH 7.0) or 2% aqueous uranyl acetate 145 
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(pH 4.0) for 1 min. The grids were then blotted on filter paper to remove the excess 146 
solution and allowed to air-dry for 10 minutes. Phages were examined by transmission 147 
electron microscopy, in the Multi-Imaging Centre (Department of Physiology, Development 148 
and Neuroscience, University of Cambridge) using a FEI Tecnai G2 transmission electron 149 
microscope (FEI, Oregon, USA). The accelerating voltage was 120.0 kV and images were 150 
captured with an AMT XR60B digital camera running Deben software. 151 
Host range determination 152 
A collection of enterobacterial strains was assembled to test their sensibility to φMAM1. 153 
Top agar overlays containing 4 ml of 0.35% (w/v) LBA and 200 µl of an overnight culture of 154 
the bacteria strain to test were poured onto a solid LBA plate and allowed to set. A 10 µl 155 
sample of serial dilution high-titre phage lysate of φMAM1 was spotted onto each bacteria 156 
overlay and the plates were incubated overnight at 30 ºC or 37 ºC. Ten microlitres of 157 
phage buffer were also added as negative dilution control. After incubation, each plate was 158 
scored for lysis. Efficiency of plaquing (EOP) was determined by dividing the phage titre of 159 
the φMAM1-sensitive strain by that of the wild type reference strain, Serratia plymuthica 160 
A153. EOP assays were performed in triplicate. 161 
Transduction assays 162 
Phage lysates were prepared on bacterial strains carrying the desired mutation or plasmid. 163 
Phages were initially tested for their ability to transduce the Tn-KRCPN1 transposon from 164 
oocJ::Tn-KRCPN1 and admK::Tn-KRCPN1 mutations into wild type S. plymuthica A153. 165 
The transduction protocol was optimized based on the incubation time, temperature, 166 
multiplicity of infection (m.o.i.) and number of bacterial cells. An appropriate volume of a 167 
high-titre transducing lysate was added to a 10 ml overnight culture of the recipient strain 168 
(~1 x 1010 total bacterial cells) to give the desired m.o.i. The mixture was incubated at 30 169 
ºC for 30 minutes (1 h for Sma 12), pelleted by centrifugation (4.000 g for 10 min at 4 ºC) 170 
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and washed twice with 10 ml of LB to remove any remaining lysate. The cells were 171 
resuspended in 5 ml of LB and 100 µl aliquots of the cell mixture were spread onto LBA 172 
plates containing the appropriate antibiotic and the plates were incubated overnight. When 173 
the cell mixture was resuspended in small volumes (e.g. 300 µl of LB) and spread onto 174 
LBA plates, we observed a reduction in the transduction efficiency due to phage 175 
superinfection that caused lysis of transductant colonies. The transductants obtained were 176 
streaked out three times prior to use to reduce or eliminate any bacteriophage carry-over. 177 
Transductants were confirmed by screening the antibiotic resistant colonies for 178 
coinheritance of a secondary phenotype of either antifungal and antibacterial properties, 179 
auxotrophy or cellulose production (see supplementary information). During the 180 
transduction assays, controls for spontaneous resistance to antibiotics were determined by 181 
spreading 100 µl of the overnight culture onto LBA plates containing the relevant antibiotic. 182 
A 100 µl volume of the high-titre lysate was also spread on non-LBA plates to confirm 183 
lysate sterility. Transduction efficiency was defined as the number of transductants 184 
obtained per p.f.u. 185 
One-step growth curve and burst size 186 
One step growth curve experiments were performed as described previously (25). Briefly, 187 
overnight bacterial culture were adjusted to OD600 0.02 in 25 ml LB in a 250 ml flask and 188 
grown in a water bath at 30 ºC with orbital shaking (225 r.p.m.).  At OD600 0.1, 10 ml of the 189 
bacterial culture were removed into a sterile tube and pelleted at 4.000 x g for 10 min at 4 190 
ºC. Once the supernatant was removed, the pellet was resuspended in 10 ml of fresh LB 191 
and phage samples were added at an m.o.i. of 0.001. The same amount of phages was 192 
also added to 10 ml of LB, as a negative control. Phages were allowed to adsorb for 5 min 193 
at room temperature without shaking and the supernatant containing any unadsorbed 194 
phages was removed by centrifugation at 4.000 x g for 10 min at 4 ºC. Pellets were 195 
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resuspended in 10 ml LB, added to 15 ml LB in a 250 ml conical flask and the cultures 196 
were grown in a shaking water bath as described previously. Every 10 min, samples were 197 
taken and immediately titrated to determine the number of p.f.u. The final growth curve 198 
represents the number of phages per initial infectious centre.  199 
Phage adsorption 200 
Phage adsorption experiments were carried out as described previously (25). Briefly, 10 ml 201 
overnight cultures of the bacterial host, or non-host bacterial control (Serratia marcescens 202 
Db11), were infected with φMAM1 at an m.o.i. of 0.01, mixed briefly and placed on a tube 203 
roller at 30 ºC. A bacteria-free negative control was created by adding the same amount of 204 
phage to 10 ml of LB. One hundred microlitre samples were removed every 5 min and 205 
added to 900 µl of phage buffer and 30 µl of chloroform, mixed for 5 seconds and 206 
centrifuged at 13.000 x g for 1 min. The number of unadsorbed φMAM1 phage particles 207 
was determined by titrating the supernatant on 0.35% (w/v) LBA lawns, as described 208 
previously. Phage adsorption to bacteria was expressed as the number of free φMAM1 209 
particles per millilitre remaining in the supernatant, and expressed as a percentage of the 210 
number of p.f.u. ml-1 in the bacteria free negative control.    211 
Transposon mutagenesis and isolation of phage-resistant mutants.  212 
Random transposon mutagenesis of S. plymuthica A153 using Tn-KRCPN1 was 213 
performed as follows. In a biparental conjugal mating, 500 µl of overnight cultures of E. coli 214 
β2163 (pKRCPN1) and S. plymuthica A153 were mixed, collected by centrifugation, 215 
resuspended in 30 µl of fresh LB, and spotted on an LB agar plate supplemented with 300 216 
µM DAPA. After overnight incubation at 30 °C, cells were scraped off the plate and 217 
resuspended in 1 ml of LB. φMAM1-resistant mutants were selected by mixing 100 µl of 218 
the resuspended mating patch with 200 µl phage lysate (≥ 1 x 1011 p.f.u. ml-1) and 4 ml of 219 
0.35% (w/v) LBA containing 75 µg ml-1 kanamycin. The mixture was poured onto a solid 220 
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LBA plate, allowed to set and incubated overnight at 30 ºC. DAPA was not added to LBA 221 
medium to allow counterselection of the E. coli donor. The insertion site of transposon Tn-222 
KRCPN1 in the φMAM1-resistant mutants was determined using random primed PCR 223 
following the method described previously (30). 224 
Supplementary experimental procedures. In vitro nucleic acid techniques, construction 225 
of the A153 OocKmSm strain, phenotypic analysis of transductans and toxin-antitoxin 226 
abortive infection assays are given as supplementary information. 227 
RESULTS 228 
Isolation of φMAM1  229 
During environmental screening for new bacteriophages infecting clinical and 230 
environmental isolates of Serratia, we isolated 17 new phages infecting the haterumalide-231 
producing strain, Serratia plymuthica A153 (24). Isolated, plaque purified phage lysates of 232 
high titre were screened for their ability to transduce Tn-KRCPN1 chromosomal mutations 233 
into the A153 wild type strain. Of the 17 new phages, φMAM1 was the only transducing 234 
phage and was selected for further characterization.  235 
φMAM1 forms plaques ranging between 6.6 ± 0.9 and 1.2 ± 0.3 mm in diameter when the 236 
phages were titrated and plated in 0.2-0.8% agar overlays (Fig. A1). Within the tested 237 
temperatures, ranging between 25 and 37 ºC, no differences in plaque formation were 238 
observed (data not shown). φMAM1 viability was unaffected by the addition of chloroform 239 
during storage in phage buffer at 4 ºC and phage lysates retained high viability during the 240 
period of this study, 2 years (>65% of the initial titre).    241 
 242 
φMAM1 morphology 243 
Using transmission electron microscopy, the morphology of φMAM1 was determined. 244 
φMAM1 has an icosahedral and isometric head measuring 90 ± 2 nm from flat face to flat 245 
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face. Its contractile tail measures 120 ± 2 nm long and 21 ± 2 nm in diameter when 246 
extended, or 57 ± 2 nm long and 26 ± 2 nm in diameter when contracted (Fig. 1). The 247 
φMAM1 tail consists of a 11 ± 1 nm neck with a collar, a tail tube surrounded by a 248 
contractile sheath showing 24 transverse striations, a baseplate and a complex system of 249 
tail spikes (Fig. 1). Based on its morphology and according to Ackermann´s (31) 250 
classification, φMAM1 was grouped into the order Caudovirales within the Myoviridae 251 
family, which comprises 25% of the tailed bacteriophages and includes the Escherichia 252 
coli phage, T4. Morphologically, φMAM1 is very similar to Salmonella phages Vi01 (32), 253 
φSH19 (33) and SFP10 (34), Shigella phage φSboM-AG3 (35), E. coli phages CBA120 254 
(36) and PhaxI (37) and Dickeya phage LIMEstone1 (11). All these ViI-like enterobacterial 255 
bacteriophages have been described recently as members of a newly proposed genus 256 
within the Myoviridae family, “Viunalikevirus” (26). The adsorption “organelle” in 257 
“Viunalikevirus” members shows two conformations consisting of “prongs” and “umbrella-258 
like” filaments with rounded tips, both associated with the baseplate (26). Both 259 
conformations were observed in φMAM1 (Fig. 1A,B) and each of the “umbrella-like” 260 
structures shows 4 short filaments attached to the baseplate by a stalk (Fig. 1B).        261 
 262 
Biological characterization of φMAM1 263 
We evaluated the ability of φMAM1 to lyse host bacteria in liquid cultures by adding 264 
phages at different m.o.i. to S. plymuthica A153 cultures. φMAM1 infection caused a 265 
reduction in growth rate followed by a cessation of bacterial growth 30 and 90 min after 266 
phage addition, respectively. Bacterial lysis caused a decrease in the turbidity of the 267 
culture two hours after phage addition (Fig. 2A). However, a resumption of growth was 268 
observed in A153 after a prolonged incubation period (data not shown). This resumption 269 
was associated with the emergence of phage resistant mutants, since A153 isolates from 270 
late infected cultures showed φMAM1 resistance in agar lawn assays.  271 
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Phage adsorption assays confirmed that φMAM1 adsorbs rapidly to S. plymuthica A153, 272 
with more than 95% of the phage particles adsorbed within the first 5 min. The number of 273 
adsorbed phage particles reached an apparent maximum 30 min post-mixing (Fig. 2B) and 274 
this time was chosen as the incubation time in the A153 transduction assays (see below). 275 
To determine the burst size of φMAM1, one-step growth curves were carried out. φMAM1 276 
showed a latent period of ~20 min and a rise period, where the phage particles were 277 
released, of around 40 min. The average burst size was more than 300 phage particles 278 
per initial infection centre (Fig. 2C).  279 
Host range of the virulent bacteriophage φMAM1 280 
Sensitivity to φMAM1 of a collection of 25 environmental and clinical isolates of Serratia 281 
marcescens (Sma) (38) and 30 enterobacterial strains isolated from the rhizosphere of 282 
agronomic crops (39) was investigated by spotting phage lysates onto bacterial lawns. 283 
Bacterial clearing was observed on agar lawns of 17 Sma strains and in the 284 
rhizobacterium, Kluyvera cryorescens 2Kr27 (Table 1; Fig. A1). The plaques formed in the 285 
sensitive strains varied in size and were clear in most strains, but turbid in Sma 0006, Sma 286 
1047, Sma 3127, Sma 3078V and Sma S6. However, subsequent phage titrations showed 287 
no obvious plaque formation in Sma 1695 and Sma 2595. We showed that the observed 288 
lysis in the latter two strains was not due to a bacteriocin present in the phage lysate (data 289 
not shown). Further adsorption assays confirmed that φMAM1 adsorbs to Sma 1695 and 290 
Sma 2595, but with low efficiencies (Fig. A2). For strains where φMAM1 was able to form 291 
plaques, the efficiency of plaquing (EOP) was similar, except on Sma 365 (EOP of 6.1 x 292 
10-3), suggesting that there was no host controlled restriction system active against this 293 
phage in most strains (Table 1).  294 
As φMAM1 formed turbid plaques in several strains we used the protocol described by 295 
Petty et al., (25), to test for lysogeny in Sma 0006, Sma 1047, Sma 3127, Sma 3078V and 296 
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Sma S6 after φMAM1 exposure. The results were universally negative and it is reasonable 297 
to assume that this is either a virulent phage or a temperate phage with a low frequency of 298 
lysogeny.  299 
Other enterobacterial strains belonging to Dickeya, Escherichia, Pectobacterium, 300 
Citrobacter, Photorhabdus, Yersinia, Salmonella, Pantoea and Enterobacter genera were 301 
also tested for susceptibility to φMAM1 infection. None of the strains tested showed signs 302 
of φMAM1 sensitivity.   303 
 304 
φMAM1 is a generalized transducing phage 305 
As described above, φMAM1 was the only A153 infecting phage able to transduce 306 
mutations between A153 strains. No differences in the transduction efficiency were 307 
observed at different temperatures (e.g. 25, 30 and 37 ºC; not shown) or using different 308 
number of cells (e.g. 108, 109 and 1010 total bacterial cells) (Table 2). Transduction 309 
efficiency was higher at an m.o.i of 0.01 and 0.1 (>10-6 transductants obtained per p.f.u). 310 
However, the transduction efficiency decreased with higher m.o.i. probably due to φMAM1 311 
superinfection killing of the transductants (Table 2). In fact, during the transduction assays, 312 
the size of the transductants colonies after overnight incubation decreased as the m.o.i. 313 
values increased and some phage “nibbling” was observed at the edges of these colonies. 314 
Transduction efficiencies were determined in A153 and Sma 12 for several chromosomal 315 
markers including mutations in the oocydin A biosynthetic genes oocJ and oocU, the 316 
antibiotic biosynthetic genes admH and admK and the cellulose synthase regulator 317 
encoding gene bcsB, among others. Transduction efficiencies between 1.1 x 10-6 and 4.2 x 318 
10-6 were observed for the different chromosomal markers in the wild type reference strain 319 
A153 (Table 3). The frequency ranged from 2.3 x 10-6 to 7.2 x 10-6 in Sma 12 (Table 3).  320 
Transduction of a kanamycin derivative version of pECA1039 from S. plymuthica A153 to 321 
Sma 12 and Kluyvera cryorescens 2Kr27 was also demonstrated. The plasmid pECA1039, 322 
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isolated from the Gram-negative bacterium Pectobacterium atrosepticum (40), encodes 323 
the first known Type III Toxin-Antitoxin (TA) system, ToxIN, bifunctional as an abortive 324 
infection system active against many phages. However φMAM1 was not aborted by the 325 
ToxIN system. Although the plasmid transduction efficiencies were relatively high, these 326 
were one order of magnitude lower than those obtained for the transduction of 327 
chromosomal markers (Table 3). 328 
 329 
φMAM1 genome analysis 330 
φMAM1 has a dsDNA of 157,834 bp (98.5 x 106 Da) encoding 198 putative ORFs and 331 
three tRNAs genes, tRNA-Pro (CCU), tRNA-Met (AUG) and tRNA-Cys (UGU) (Fig. 3; 332 
Table A2) (24). Three different start codons, ATG (94.0%), GTG (3.5%) and TTG (2.5%), 333 
were identified. The coding sequences of φMAM1 represent 91.6% of the genome with a 334 
GC content of 52.5%. Based on BLASTP similarities and the presence of conserved 335 
domains, a predicted function was assigned to 39.8% of the identified ORFs. Within the 336 
60.2% of the genes encoding hypothetical proteins, 27.3% of them were unique to 337 
φMAM1. Genome comparison analyses showed that the genome of φMAM1 is between 338 
52.7 and 54.2% identical at the DNA level to the genomes of the seven sequenced ViI-like 339 
phages and shares between 59.0 and 64.6% of their putative ORFs (Fig. 3-4; Table A2 340 
and A3).  341 
The highly homology observed between φMAM1 and ViI-like phages led us to investigate 342 
their phylogenetic relationships. Thus, the amino acid sequences of a structural protein 343 
(major capsid protein) and a non-structural protein (DNA polymerase) were chosen to 344 
perform phylogenetic analyses. Previously, major capsid proteins and DNA polymerase 345 
were often used as phylogenetic markers (26,34,41). As expected from the phage 346 
morphology and the genomic comparison analyses, the phylogeny revealed that φMAM1 is 347 




Transcription, regulatory sequences and translation 350 
The analysis of the promoter regions of the φMAM1 genes allowed us to identify the motif 351 
TTCAATAA[N12]TATtAT in the promoters of 27 φMAM1 genes (Fig. A4A). Most (81.4%) of 352 
the φMAM1 genes containing this upstream consensus sequence encode hypothetical 353 
proteins making it difficult to predict in which stage of the lytic cycle they may be 354 
expressed. However, the motif shows similarity with the consensus sequence of the E. coli 355 
RpoD-dependent promoters (TTGACA[N15-18]TATAAT) (42) and to the conserved motif 356 
identified in T4 early promoters (43) perhaps indicating that these genes are expressed in 357 
early stages of the phage lytic cycle.  358 
In general, late transcription is responsible for the synthesis of phage structural 359 
components, besides other recombination and replication factors (43). Based on the 360 
consensus sequence of T4 late promoters (TATAAATA) (44), we identified 16 putative late 361 
promoters (Fig. A4B). Seven of them, including PMAM_038 (upstream of a tail spike head-362 
binding protein gene), PMAM_135 (baseplate hub subunit), PMAM_142 (Gp32 ssDNA binding 363 
protein) and PMAM_143 (Gp19 baseplate tail tube) are expected to be late genes. Several 364 
proteins have been described as involved in late transcription in T4-related phages and 365 
φMAM1 encodes orthologs of all of them - including the transcription co-activator Gp33 366 
(MAM_140), sigma factor Gp55 (MAM_108), sliding clamp protein Gp45 (MAM_078) and 367 
the clamp-loader proteins Gp44 (MAM_079) and Gp62 (MAM_080) (43,44). Thirty six Rho-368 
independent terminators were identified in the genome of φMAM1, four of them predicted 369 
to be on late transcripts (Fig. A4C).  370 
 371 
Structural components 372 
Mass spectrometry analysis identified 41 structural proteins in Vi01 (32) and 39 in 373 
LIMEstone1 (11), two ViI-like phages. However, the function of 33% (11) and 41% (32), 374 
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respectively, of the identified structural proteins is unknown. With the exception of 6 and 4 375 
unknown structural proteins identified in Vi01 and LIMEstone1, respectively, orthologs for 376 
the remaining structural proteins were found in φMAM1 (Table A2). However, genome 377 
comparison analyses showed that major differences were observed in a 14.7-kb region 378 
encoding the host-recognition elements, the tail spike proteins (TSPs) (Fig. 3-4; Table A2). 379 
Other φMAM1 structural proteins are described in the supplementary material. 380 
Most of the sequenced ViI-like phages encode four tail spike proteins (26) and the 381 
presence of these TSPs has been confirmed by mass spectrometry analyses in Vi01 (32) 382 
and LIMEstone1 (11). φMAM1 also encodes four putative TSPs, three of which 383 
(MAM_031, MAM_034, MAM_037) contain a pectate lyase domain (Table A2). The TSP 384 
MAM_031 is a 987 amino acid protein and BlastP analyses showed that its first 262 amino 385 
acids are 45-49% identical (64% similar) to the N-terminal region of TSPs encoded by all 386 
the seven sequenced ViI-like phages. However, the N-terminal regions of the other three 387 
putative TSPs (MAM_034, MAM_037, MAM_038) are less conserved and appear to be 388 
more specific to φMAM1. Thus, MAM_034 is 37-39% identical (53-55% similar) from amino 389 
acid 23 to amino acid 114 to TSPs present in SFP10, CBA120 and PhaxI, whereas the 390 
amino acids 25-211 of the N-terminal region of MAM_037 are 34% identical (54% similar) 391 
to the TSP-1 of φSH19. Finally, the first 97 residues of the 602 amino acid TSP MAM_038 392 
are 29% identical (46% similar) to the TSP Vi01_170c of the Salmonella phage Vi01 393 
(Table A2). Interestingly, the BlastP analyses also showed that the C-terminal regions of 394 
the four φMAM1 putative TSPs show similarity to several proteins of unknown function 395 
encoded by Serratia plymuthica AS9 (45), Serratia plymuthica AS12 (46) and S. 396 
proteomaculas 568 (47), bacterial strains closely related to the φMAM1 host, S. plymuthica 397 
A153.  398 
 399 
Capsular antigen is the receptor for φMAM1  400 
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Group 1 capsular polysaccharides (CPS) and lipopolysaccharide (LPS) O-antigen 401 
biosynthetic gene clusters of Enterobacteriaceae have important common features. In fact, 402 
research on the biosynthesis of LPS O-antigens has been extrapolated to understand the 403 
assembly of CPS (48). Thus, both CPS and LPS O-antigen gene clusters share many 404 
genes and they are located between the galF and gnd genes in strains belonging to 405 
Escherichia, Salmonella, Shigella and Enterobacter genera (49-52). However, it is the 406 
presence of the wza, wzb and wzc genes that differentiates these CPS and LPS loci (48).  407 
All the A153 phage resistance mutations mapped in a 17.6-kb region between galF and 408 
gnd (Fig. A5). The 17.6-kb region consists of 13 genes predicted to form an operon (Fig. 409 
A5) and, consequently, the insertion of the Tn-KRCPN1 transposon may cause polar 410 
effects in the expression of the downstream genes. In this region, wza, wzb and wzc 411 
genes are involved in the synthesis, export and regulation of CPS (48,53). The hexose-1-412 
phosphate transferase encoding gene (wbaP) was proposed to be involved in the initiation 413 
of the capsular polysaccharide synthesis (48). The polysaccharide can be extended by the 414 
action of glycosyltransferases, four of which are encoded by genes in this region. The 415 
region also contains the gene wzx, encoding a flippase required for the translocation of the 416 
CPS biosynthetic units across the inner plasma membrane (53). Not surprisingly, the 417 
region also encodes a hypothetical protein that is 31% identical (49% similar) to the C-418 
terminal region of the TSP MAM_034 protein. 419 
During the characterization of the phage resistant mutants, we noted that they exhibited a 420 
“rough” colony morphology characteristic of some CPS defective mutants and they 421 
showed the same antifungal activity as the parental A153 strain (Fig. A5). Adsorption of 422 
φMAM1 to all the phage-resistant mutants was abolished, confirming the role of CPS as 423 
receptors (Fig. 2B). 424 
 425 
Mobilization of the oocydin A gene cluster by transduction 426 
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The abundance and diversity of secondary metabolite gene clusters in some bacterial 427 
strains, and their irregular distribution, raised the possibility of horizontal transfer of such 428 
gene clusters between bacterial strains (54). Recently, we identified a 77-kb gene cluster 429 
involved in the biosynthesis of the haterumalide, oocydin A (ooc) (30). Given the high 430 
transduction efficiency and its large genome size, we decided to use φMAM1 as a genetic 431 
tool for mobilizing the ooc gene cluster. Thus, we constructed the strain S. plymuthica 432 
A153 OocKmSm containing a kanamycin resistance and a streptomycin resistance 433 
cassette up- and downstream of the ooc gene cluster, respectively. The OocKmSm strain 434 
was the donor strain used to transduce the ooc gene cluster into the non-oocydin A 435 
producing strain OocEV, containing in-frame deletions in oocE and oocV.  Among the 436 
transductants, 17.7 % and 9.5 % of the streptomycin and kanamycin resistant colonies 437 
showed restoration of the oocydin A production, respectively (Table 4; Fig. 5). The ooc 438 
gene cluster was transduced into OocEV with a frequency of 1.9 x 10-7 and the production 439 
of the haterumalide was fully restored in the kanamycin and streptomycin doubly resistant 440 
colonies (Table 4). We also tried to transduce the ooc gene cluster into the other φMAM1 441 
sensitive strains. However, no transductants were obtained with these strains presumably 442 
due to insufficient DNA homology between the donor (A153) and the recipient strains to 443 
enable homologous recombination. 444 
DISCUSSION 445 
Horizontal gene transfer (HGT) is a powerful source of genomic diversity and contributes 446 
actively to the rapid evolution of prokaryotes (55). In fact, it has been estimated that up to 447 
80% of known bacterial and archaeal genomes may be affected by HGT (56). From an 448 
ecological perspective, the acquired genes may represent an adaptive advantage for the 449 
microorganisms under certain environmental conditions (57,58). Transduction has been 450 
described in natural environments such as sewage, fresh and sea water and on plant 451 
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leaves reflecting its importance in microbial ecology and in the evolution of microbial 452 
populations (14,56).  453 
Several Serratia transducing bacteriophages have been identified previously (25,59,60). 454 
However, to our knowledge, φMAM1 is the first transducing phage described for Serratia 455 
plymuthica. Compared with other enterobacterial phages (25,61,62), the high transduction 456 
efficiency mediated by φMAM1, together with its large genome (it can transduce around 457 
3% of the A153 host genome) and its wide host range, makes this new phage an 458 
extraordinary tool for bacterial genetics. Additionally, given the DNA homology between 459 
φMAM1 and the other sequenced ViI-like phages (Table A3; Fig. 3-4), it remains possible 460 
that all these “Viunalikevirus” bacteriophages will be highly efficient transducers. 461 
Consistent with this notion, Salmonella phage Vi01 was shown to be a transducing phage 462 
twenty years ago (63). 463 
We have shown recently that the oocydin A gene cluster is present in four plant associated 464 
bacteria belonging to Serratia and Dickeya genera (30). The fact that the genomic context 465 
of the ooc gene cluster in three of these bacteria is different, together with the identification 466 
of sequences similar to a bacteriophage P4 integrase bordering the cluster in one of the 467 
strains, suggests that the gene cluster was previously acquired by HGT (30). High 468 
bacterial density has been associated with elevated transduction rates (64), perhaps 469 
indicating that the rhizosphere may be a niche conducive to higher transduction 470 
frequencies. In agreement with this idea, we have found that several Serratia strains 471 
isolated from the rhizosphere of the same crop are able to produce oocydin A (M.A. Matilla 472 
and G.P.C. Salmond, unpublished data). This observation indicates that the ooc gene 473 
cluster is more widespread than perhaps expected and it is possible that it has been 474 
transferred between rhizosphere strains by transduction. 475 
φMAM1 contains three tRNA genes located together in a cluster. Although tRNA-Met is 476 
conserved within most the sequenced ViI-like phages, thus far tRNA-Pro and tRNA-Cys 477 
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genes are unique to φMAM1. The function of phage tRNA is still an open debate but it has 478 
been suggested that a positive correlation exists between the tRNA distribution and phage 479 
codon usage (65). Although this correlation is absent in φMAM1 (data not shown), phage 480 
tRNAs have been associated with overcoming differences in the GC content between the 481 
phages and their hosts (66). Interestingly, the G+C content of the φMAM1 tRNA genes 482 
(56.2%) and the genome of its host S. plymuthica A153 (55.9%) (24) are similar.  483 
Many reports have reported promiscuity in enterobacterial phages (34,35,60,67,68) and 484 
φMAM1 is another noteworthy example. φMAM1 infects 68% of the Serratia marcescens 485 
strains tested and a rhizobacterial strain from the Kluyvera genus. φMAM1 sensitive 486 
strains include 7 environmental and 10 clinical isolates, including the model bacterium 487 
Sma 365 and the carbapenem-resistant, Sma S6. Additionally, the C-terminal region of the 488 
TSPs from φMAM1 show similarity to several hypothetical proteins encoded by strains 489 
such as Serratia proteamaculans (Spro) 568, a rhizobacterial strain with a genome highly 490 
similar to that of A153 (47). TSP proteins are involved in the recognition of host receptor(s) 491 
and the analysis of their C-terminal regions has been predicted as a rational approach for 492 
the identification of new phage hosts (26,69,70). Strain Spro 568 shows interesting 493 
biocontrol properties including plant growth promotion and production of exoenzymes (47), 494 
however its genome does not contain genetic information for the synthesis of oocydin A. 495 
We were able to transduce the complete, functional ooc gene cluster back into the non-496 
oocydin A producer strain OocEV at high efficiency (Table 4, Fig. 5). Thus, φMAM1 might 497 
prove an effective tool for mobilizing the ooc gene cluster into non-oocydin producers, 498 
thereby engineering synthetic derivative strains with enhanced biocontrol properties, 499 
perhaps mimicking a process that is likely to be occurring naturally in the environment. 500 
Mechanisms of bacterial defence against bacteriophages include the mutation of host 501 
receptors, restriction of the incoming phage DNA, abortive infection (i.e. through toxin-502 
antitoxin systems) and CRISPR-Cas systems (71). Toxin-antitoxin (TA) systems are 503 
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generally comprised of two genes encoding a toxin component and its cognate antitoxin 504 
(72). TA loci are widespread in bacteria and they have been found in plasmids and 505 
bacterial chromosomes, strongly implicating HGT in the dissemination of these systems 506 
(72,73). In 2009, we identified and characterised the first Type III protein-RNA TA system, 507 
encoded by the plasmid pECA1039 of the phytopathogen, Pectobacterium atrosepticum 508 
(40). Using φMAM1, transduction of pECA1039-km3 between different species of Serratia 509 
and between two bacterial genera was demonstrated (Table 3). Given the importance of 510 
anti-viral abortive infection systems in the population biology of bacteria that are constantly 511 
assaulted by viral parasites, these observations reinforce the notion that phages are key 512 
players in the dissemination of important genetic information - and therefore in adaptive 513 
bacterial evolution in changing ecological niches. Interestingly, neither the P. atrosepticum 514 
TA system nor the Type III TA system encoded by the insect pathogenic bacterium 515 
Photorhabdus luminescens (72) were able to protect S. plymuthica A153 from φMAM1 516 
infection (not shown) suggesting that this phage evolved the capacity to naturally 517 
circumvent the abortive infection system. However, another phage defensive 518 
mechanism(s) may be present in the φMAM1 sensitive strains Sma 1695 and Sma 2595 519 
since no plaque formation was observed in these two strains.  520 
The recognition of host receptors by ViI-like phages is dependent on tail spikes proteins 521 
(TSP) instead of T4-like tail fibers (26). Based on the crystal structure of the C-terminal 522 
TSP of the Salmonella phage Det7 (69), a phage morphologically similar to φMAM1, 523 
several authors have proposed a role for the TSP regions. Thus, the N-terminal region 524 
may bind to the phage base plate transferring the signal to the tail structure after phage 525 
adsorption whereas the C-terminal region is responsible of the recognition of the host 526 
receptor (26,36,69).  As observed in other ViI-like phages (26), the C-terminal region of the 527 
TSPs from φMAM1 contains domains with enzymatic activity. These enzymatic domains 528 
are required for phage infection and it has been proposed that they serve to separate the 529 
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phage from cell debris after bacterial lysis (69). TSPs from the ViI-like Salmonella phages 530 
Vi01 (32) and Det7 (69) contain an acetyl transferase and an O-antigen binding domain, 531 
respectively, responsible for the recognition of the exopolysaccharide capsule and LPS as 532 
receptors. TSP-2 of the phage φSH19 contains a pectate lyase domain and it was 533 
suggested that it may have a role in the cleavage of glycosidic bonds (33). In agreement 534 
with these observations, capsular antigen appears to be the receptor for φMAM1 and, 535 
interestingly, three of its four TSPs contain a putative pectate lyase domain. Recently, 536 
capsular polysaccharides also have been proposed to be the receptor in the ViI-like 537 
Klebsiella phage o507-KN2-1 (74). Future synthetic biology approaches will involve 538 
engineering of highly efficient transducing phages with promiscuous host ranges through 539 
exploitation of structural knowledge that underpins the exquisite molecular specificity seen 540 
in these phage-host interactions.  541 
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Serratia plymuthica A153  Rhizosphere isolate, oocydin A+   19  1  Clear  1.5 
Serratia marcescens 1695  Clinical isolate, non‐pigmented  42  ‐b  Turbid  ‐ 
S. marcescens 0006  Environmental isolate, non‐pigmented  42  0.6 c  Turbid  0.1 
S. marcescens 1047  Clinical isolate, non‐pigmented  42  0.5 c  Turbid  0.3 
S. marcescens 0026  Environmental isolate, non‐pigmented  42  1.2  Clear  0.7 
S. marcescens 3078  Clinical isolate, pigmented  42  1.2  Clear  1 
S. marcescens 0038  Environmental isolate, pigmented  42  0.3  Clear  1 
S. marcescens 3127  Clinical isolate, non‐pigmented  42  0.3  Turbid  0.5 
S. marcescens 0035  Environmental isolate, pigmented  42  0.1  Clear  0.5 
S. marcescens 12  Clinical isolate, non‐pigmented  42  0.3  Clear  0.1 
S. marcescens 0040  Environmental isolate, pigmented  42  1.4  Clear  1.5 
S. marcescens 2595  Clinical isolate, non‐pigmented  42  ‐ b  Turbid  ‐ 
S. marcescens 3127  Clinical isolate, pigmented  42  0.6  Clear  1 
S. marcescens 3078V  Spontaneous non‐pigmented variant of Sma 3078  42  0.9  Turbid  0.8 
S. marcescens ATCC 274  Clinical isolate, pigmented  66  0.5  Clear  0.5 
S. marcescens S6  Clinical isolate, non‐pigmented  76  0.6  Turbid  0.8 
S. marcescens 365  Lab stock, pigmented  L. Debarbieux  6.1 x 10‐3  Clear  0.1 
S. marcescens 2170  Lab stock, pigmented  T. Watanabe  0.9  Clear  1 
Kluyvera cryorescens 2Kr27  Rhizosphere isolate  39  0.4  Clear  0.3 
aEOP was determined by dividing the phage titre of the φMAM1-sensitive strain by that of the wild type 783 
reference strain, Serratia plymuthica A153. 784 
bNo plaques observed. Adsorption assays confirmed that φMAM1 adsorbs to Sma 1695 and Sma 2595. 785 
cNo phage plaques were observed at 30 ºC. Phage plaques arose at 37 ºC in Sma 0006 and Sma 1047.  786 










Table 2: Frequency of transduction of φMAM1 795 
Number of A153 cells  m.o.i.  Transduction efficiencya,b  Standard deviationb  
1 x 1010  10     < 1.0 x 10‐11  ‐ 
   1  3.4 x 10‐7  4.1 x 10‐8 
   0.1  2.7 x 10‐6  2.5 x 10‐7 
   0.01  3.3 x 10‐6  6.7 x 10‐7 
1 x 109  10    < 1.0 x 10‐10 ‐
   1  3.0 x 10‐7 1.8 x 10‐8
   0.1  4.5 x 10‐6 3.0 x 10‐7 
   0.01  5.8 x 10‐6  9.7 x 10‐7 
1 x 108  10               < 1.0 x 10‐9  ‐ 
   1  2.8 x 10‐7  5.9 x 10‐8 
   0.1  7.4 x 10‐6  1.2 x 10‐6 
   0.01  6.8 x 10‐6  0.9 x 10‐6 
aEfficiency of transduction, defined as the number of transductants per p.f.u. obtained carrying the oocJ::Tn-796 
KRCPN1 marker in the A153 recipient. 797 

















Table 3: φMAM1 transduction efficiency of different markers within Serratia 813 
plymuthica A153, Serratia marcescens 12 and Kluyvera cryorescens 2Kr27. 814 







Transduction within Serratia plymuthica A153 
VN1 admH::Km A153 Antibiotic- 1.8 x 10-6 2.5 x 10-7 
VN2 admK::Km A153 Antibiotic- 1.1 x 10-6 1.8 x 10-7 
MMnO13 oocJ::Km A153 Oocydin A- 2.7 x 10-6 2.5 x 10-7 
MMnO15 oocU::Km A153 Oocydin A- 4.2 x 10-6 2.3 x 10-7 
OocKmSm Km,Sm A153 Oocydin A+ 2.1 x 10-7 3.1 x 10-8 
BcsB bcsB::Sm A153 Cellulose- 1.3 x 10-6 1.1 x 10-7 
A153 pECA1039-km3 A153 ToxIN+ 2.5 x 10-7   7.4 x 10-8 
Transduction within Serratia marcescens 12 
Sma12I luxI::Km Sma 12 Lactone- 5.3 x 10-6 1.3 x 10-7 
Dho narX::Km Sma 12 Pyrimidine auxotroph 6.6 x 10-6 2.7 x 10-7 
Cps cps::km Sma 12 Uracil auxotroph 2.3 x 10-6 6.9 x 10-8 
Sma12S luxS::Km Sma 12 Autoinducer-2- 7.2 x 10-6 8.2 x 10-7 
Intergeneric transduction  
A153 pECA1039-km3 2Kr27 ToxIN+ 2.7 x 10-7 2.6 x 10-8 
A153 pECA1039-km3 Sma 12 ToxIN+ 4.8 x 10-8 9.6 x 10-9 
aThe number of transductants showing co-inheritance of the antibiotic resistance and the listed phenotype. 815 
Transduction efficiency is expressed as the number of transductants per p.f.u. 816 
bMean and standard deviation of three independent experiments are shown. 817 


























Restoration of oocydin A 
production in transductants 
(%) 
OocKmSm Km,Sm OocEV Km 1.2 x 10-6 4.7 x 10-7 17.7 ± 4.8  
OocKmSm Km,Sm OocEV Sm 2.1 x 10-6 4.2 x 10-7 9.5 ± 2.0 
OocKmSm Km,Sm OocEV Km,Sm 1.9 x 10-7 1.7 x 10-8 100 ± 0 
aOocEV is a markerless, double in-frame deletion mutant defective in the genes oocE and oocV (Table A1).  830 
























FIGURE AND FIGURE LEGENDS 853 
 854 
 855 
Fig. 1. Transmission electron micrographs of phage φMAM1. A, Intact virion with 856 
folded “prong-like” structures. B, Intact virion with unfolded “prong-like” structures. A detail 857 
of an unfolded structure with the four tail-spike proteins (TSP) attached to the baseplate is 858 
also shown. C, Intact virion with contracted tail, deformed head and TSP structures. D, 859 
φMAM1 phage particle lacking the adsorption structures and with the central tube 860 
exposed. φMAM1 particles were stained with uranyl acetate (A) or ammonium tungstate 861 






Fig 2. Biological characterization of φMAM1. A, Serratia plymuthica A153 growth 866 
curves in the presence and absence of φMAM1. Phage was added at an m.o.i. of 0.1 and 867 
1 to A153 in the early exponential phase of growth as described Petty et al., (25). The 868 
arrow indicates the point of addition of φMAM1. B, Adsorption of φMAM1 to A153 and 869 
A153 phage resistant (PR) mutants. The φMAM1 insensitive strain Serratia marcescens 870 
Db10 was used as negative control for the adsorption. Description of the strains and the 871 
location of the transposon insertion points are shown in Table A1 and Fig. A5, 872 





Fig. 3: Genome map of phage φMAM1. The physical locations by strand of all ORFs are 876 
shown on the outer ring. Colour code representing the functional category of each gene is 877 
given where possible. The proposed structural genes (dark brown) are based on previous 878 
mass spectrometry analyses (11,32). The region encoding the host-recognition 879 
determinants, the tail spike proteins, is indicated with an asterisk. The three bluish and 880 
reddish internal rings represent the tBLASTx results against the ViI-like phages Vi01 (outer 881 
ring), φSboM-AG3 (middle ring) and LIMEstone1 (inner ring). GC content and GC skew 882 
39 
 



















Fig. 4. DNA homology between the genome of φMAM1 and the genomes of seven 900 
sequenced ViI-like phages. The alignments represent the percentage of DNA homology 901 
between the genome of φMAM1 and those of PhaxI (A; 37), LIMEstone1 (B; 11), CBA120 902 
(C; 36), φSH19 (D; 33), SFP10 (E; 34), Vi01 (F; 32), and φSboM-AG3 (G; 35). The regions 903 
encoding the host-recognition determinants, the tail spike proteins, are highlighted. 904 













Fig. 5. Mobilization of the oocydin A gene cluster into the non-producing Serratia 916 
plymuthica A153 OocEV mutant through transduction mediated by phage φMAM1. 917 
Production of oocydin A, shown as the ability of inhibiting the growth of the plant 918 
pathogenic fungi Verticillium dahliae, in several A153 derivative strains. The bioassays 919 
were performed as described previously (30). The assays were repeated at least five 920 
times, and representative results are shown. Bacterial strains used are listed in Table A1. 921 
 922 
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